17 April 2015 - Deborah Wilkes
Archived
Weifa's shareholders have given the go-ahead for the Norwegian company's plan to split off its active pharmaceutical ingredients (API) business and focus on consumer health.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.